No Data
No Data
Press Release: Avant Technologies and Ainnova Tech Begin Acquisition Talks Ahead of FDA Pre-Submission Meeting
Express News | Avant Technologies and Ainnova Request Pre-Submission Meeting With US FDA for Visionai Platform Technology
Avant Technologies and Ainnova Request Pre-Submission Meeting With US FDA for VisionAI Platform Technology
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
AI replacing animal experiments? A piece of news from the FDA has boosted the concept stocks of AI medicine development, with RXRX rising by over 30% at one point.
The news that the USA Food and Drug Administration (FDA) claims to gradually replace animal testing requirements has driven stock prices of AI pharmaceutical development Concept companies in the USA today.
Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City